alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 65, Number 231 (Thursday, November 30, 2000)]
[Notices]
[Page 71323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30515]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Endocrine Disruptors: Epidemiological Approaches, 
RFA OH-01-001

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Endocrine Disruptors: Epidemiological 
Approaches, RFA OH-01-001, meeting.
    Times and Dates: 8 a.m.-8:30 a.m., February 1, 2001 (Open), 8:30 
a.m.-5 p.m., February 1, 2001 (Closed), 8 a.m.-5 p.m., February 2, 
2001 (Closed).
    Place: Embassy Suites Hotel, 315 Julia Street, New Orleans, 
Louisiana 70130.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Associate Director for 
Management and Operations, CDC, pursuant to Public Law 92-463.
    Matter to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement RFA OH-01-001.
    Contact Person for more Information: Pervis C. Major, Ph.D., 
Scientific Review Administrator, National Institute for Occupational 
Safety and Health, 1095 Willowdale Rd., Morgantown, WV 26505. Phone 
304/285-5979, e-mail <a href="/cdn-cgi/l/email-protection#1848557972776a587b7c7b367f776e"><span class="__cf_email__" data-cfemail="97c7daf6fdf8e5d7f4f3f4b9f0f8e1">[email protected]</span></a>.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: November 21, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention CDC.
[FR Doc. 00-30515 Filed 11-29-00; 8:45 am]
BILLING CODE 4163-19-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### Frank TICE, Appellant, v. STATE of Texas, Appellee.

No. 21593.

Court of Criminal Appeals of Texas.

April 9, 1941.

H. R. Bishop, of Fort Worth, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

KRUEGER, Judge.

The conviction is for burglary of a private residence at night. The punishment assessed is confinement in the state penitentiary for a period of 25 years.

Since perfecting his appeal, appellant has filed in this court his written motion, duly verified, requesting the privilege of withdrawing said appeal. The request is granted and the appeal is ordered dismissed.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the judges of the Court of Criminal Appeals and approved by the court.
##### 



EXHIBIT 99.2

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002,
18 U.S.C. SECTION 1350

In connection with the Quarterly Report of Digene Corporation (the
Company) on Form 10-Q for the quarter ended March 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I,
Charles M. Fleischman, Chief Financial Officer of the Company, certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350 that, to my knowledge:

1.     The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and

2.     The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.



| | /s/  Charles M. Fleischman

Charles M. Fleischman
Chief Financial Officer
May 7, 2003
| | -------------------------------------------------------------------------------------
[Federal Register Volume 65, Number 233 (Monday, December 4, 2000)]
[Notices]
[Page 75677]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30858]


-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

TIME AND DATE: 11:00 a.m., Friday, December 22, 2000.

PLACE: 1155 21st St., N.W., Washington, D.C., 9th Floor Conference 
Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 00-30858 Filed 11-30-00; 10:46 am]
BILLING CODE 6351-01-M
#### E. E. FANN v. STATE.

No. 21228.

Court of Criminal Appeals of Texas.

Oct. 23, 1940.

H. R. Rolston, of Lufkin, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

KRUEGER, Judge.

The offense charged is a violation of the Local Option Law relating to intoxicating liquor. The punishment assessed is a fine of $125.

The question here presented is the same as that which was before the court in the case of Newberry v. State, Tex.Cr.App., 143 S.W.2d 962, this day decided. For the reasons therein stated, the judgment of the trial court in the present instance is reversed and the cause remanded.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the Judges of the Court of Criminal Appeals and approved by the Court.
Exhibit
32.1




CERTIFICATION
OF CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Annual Report of Moller International (the "Company") on
Form 10-K for the year ended June 30, 2009 as filed with the Securities and
Exchange commission on the date hereof (the "Report), Paul S. Moller, as Chief
Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to
the Best of his knowledge, that:




(1) The
Report fully complies with the requirements of section 13(a) of the Securities
Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.




Date: 10/13/2009




Signed:




/s/
Paul S. Moller


CEO and
President
.RadToolTip_Default.rtLoading{background:url('WebResource.axd?d=ll2Mw9hd_3R9LZv-Bbg63Fta1JlpJM4cpl5b-T7iScwlkY8D8d6bAlLaoqCce8Y-rWoOSiKqfYjuq37cmMaqD4pnZjbb-1Hs3omVw70fgNMIbnTMKy38vTrtDfo1&t=638258155382125817') no-repeat center}.RadToolTip_Default .rtWrapper .rtWrapperTopLeft,.RadToolTip_Default .rtWrapper .rtWrapperTopRight,.RadToolTip_Default .rtWrapper .rtWrapperBottomLeft,.RadToolTip_Default .rtWrapper .rtWrapperBottomRight,.RadToolTip_Default .rtWrapper .rtWrapperTopCenter,.RadToolTip_Default .rtWrapper .rtWrapperBottomCenter,.RadToolTip_Default table.rtShadow .rtWrapperTopLeft,.RadToolTip_Default table.rtShadow .rtWrapperTopRight,.RadToolTip_Default table.rtShadow .rtWrapperBottomLeft,.RadToolTip_Default table.rtShadow .rtWrapperBottomRight,.RadToolTip_Default table.rtShadow .rtWrapperTopCenter,.RadToolTip_Default table.rtShadow .rtWrapperBottomCenter,.RadToolTip_Default .rtCloseButton{background-image:url('WebResource.axd?d=FMcut1qn97sGkVbW6mduhM5nlYEYgIsdeSh2vMptJiGeIKbwJvnhk_Zo0JQgO2FDb5V9O4C3Y2ks9idrthtcILYg484xDxAgIrscXDkDESsJQdSRB-tNjPkn48ty8xGBKtN9Sg2&t=638258155382125817')}.RadToolTip_Default .rtWrapper .rtWrapperLeftMiddle,.RadToolTip_Default .rtWrapper .rtWrapperRightMiddle,.RadToolTip_Default table.rtShadow .rtWrapperLeftMiddle,.RadToolTip_Default table.rtShadow .rtWrapperRightMiddle{background-image:url('WebResource.axd?d=yTmZJFyrKBE-PqovU6gD28TIndmi65FeLB_ymjmoGtqzAuC8pUj9h0Z0YQHoqrUAzTy461dZfUGe6222uJk2En4etfBuRYTBou_rugnfetDNhm6KhDgINVmAQLCtqqg73UKNI6rxO3drBoPk0&t=638258155382125817')}.RadToolTip_Default .rtWrapper .rtWrapperContent{background-color:#fff;color:#333}.RadToolTip_Default .rtTitlebar{color:#333}.RadToolTip_Default .rtCallout{background-image:url('WebResource.axd?d=lokbm08SifPsaSPYgQBjYTwxCXuzoqOeTSKOjS3jCMk_KnX-CtY07O0QBCNOBBp_CGmAcSkM17MbKMk8QInCblPhUvw2JKRvRrCfI-OtgMLsZfsjFxmjduTucNuUxNJIL36Kyw2&t=638258155382125817')}
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of Conmed Healthcare Management, Inc. (the
“Company”) on Form 10-Q for the period ended September 30, 2010 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Richard W. Turner, Chairman and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:




(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and




(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





November
12, 2010


By
      /s/ Richard W. TurnerRichard
      W. Turner, Ph.D.Chairman
      and Chief Executive Officer




A
signed original of this written statement required by Section 906 has been
provided to and will be retained by Conmed Healthcare Management, Inc. and will
be furnished to the Securities and Exchange Commission or its staff upon
request.
#### The People of the State of New York, Respondent, v Robert A. Richer, Appellant.

Judgment unanimously affirmed. Memorandum: Defendant argues that Supreme Court erred in refusing to suppress his statement because a combination of two factors rendered his waiver unintelligent and unknowing. He claims that the police misled him by arresting him on a bad check charge, *Mirandizing*him *(see, Miranda v Arizona,*384 US 436) and then conversing with him about unrelated sexual abuse charges leading to the instant conviction. He further claims that the existence of a psychiatric condition clouded his judgment. We disagree. Police deception concerning the scope of questioning does not invalidate a *Miranda*waiver unless there is a showing that defendant thereby was denied due process or that the deception induced a false confession *(People v Hall,*152 AD2d 948, *lv denied*74 NY2d 847). There was no such showing in this case, nor is there any showing that his psychiatric condition, by itself, rendered his waiver invalid.

Defendant’s argument that the indictment is duplicitous is unpreserved for appellate review and we decline to reach it in the interest of justice. (Appeal from judgment of Supreme Court, Monroe County, Bergin, J.—attempted rape, first de*911gree.) Present — Callahan, J. P., Doerr, Boomer, Pine and Law-ton, JJ.
Power of Attorney



 Exhibit 10.26 
  
 Power of Attorney 
  
 We, Legend Holdings Limited (“this Company”), a Chinese company with Business License No.: 1100001420507(2—1), and holder of 51% of the
entire equity interests in Lenovo Security Technologies (Beijing), Inc. (“LWY”) (“Our Shareholding”), hereby irrevocably authorize Lenovo-AsiaInfo Technologies, Inc. (“LAI”) to exercise the following rights relating to
Our Shareholding during the term of this Power of Attorney, in consideration of a fixed fee of RMB100,000 per annum (the “Fixed Fee”) which shall be payable no later than December 19, 2011. 
  
 LAI is hereby authorized to act on behalf of ourselves as our exclusive agent
and attorney with respect to all matters concerning Our Shareholding, including without limitation: 1) attend shareholders’ meetings of LWY; 2) exercise all the rights of a shareholder that we are entitled to under the laws of China and
LWY’s Articles of Association, including but not limited to the sale or transfer or pledge or disposition of Our Shareholding in part or in whole; and 3) designate and appoint on behalf of ourselves, the legal representative (chairperson), the
directors (except that one of the directors may be appointed by us), supervisor, the chief executive officer and other senior management members of LWY. 
  
 Without limiting the generality of the powers granted hereunder, LAI shall have the power and authority under this Power of Attorney to execute the Equity
Transfer Arrangement Agreement, to which we are a party, and any share transfer contract contemplated therein, on behalf of ourselves, and to effect the terms of the Share Pledge Agreement to which we are a party, on behalf of ourselves, both dated
the date hereof. 
  

 1 








 All the actions associated with Our Shareholding conducted by LAI in accordance with this Power of
Attorney shall be deemed as our own actions, and all the documents related to Our Shareholding executed by LAI in accordance with this Power of Attorney shall be deemed to be executed by us. We hereby acknowledge and ratify those actions and/or
documents by LAI; provided, however, that the aforesaid actions and/or documents shall comply with the related laws and regulations of the PRC, and the Articles of Association of LWY. 
  
 LAI is entitled to re-authorize or assign its rights related to the aforesaid matters to any other person or entity at its
own discretion by giving written notice to us. 
  
 This Power of
Attorney shall be irrevocable and continuously valid from the date of execution of this Power of Attorney until December 19, 2011. 
  
 During the term of this Power of Attorney, we hereby waive all the rights associated with Our Shareholding, which have been authorized to LAI through this
Power of Attorney, and shall not exercise such rights by ourselves. 
  
 This Power of Attorney is written in Chinese and English; in case there is any conflict between the Chinese version and the English version, the Chinese version shall prevail. 
  

 2 









			
	Legend Holdings Limited
		
	Representative:	 	 /s/ Tang Xudong


	Name:	 	Tang Xudong
	Title:	 	Vice President
	
	December 2, 2004


  

 3
US Oncology, Inc.



EXHIBIT 32.2



CERTIFICATION PURSUANT TO

18 U.S.C.
SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of US Oncology, Inc. (the Company) on Form 10-Q for the period ending September 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report),
I, R. Dale Ross, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                         |  |  | 
|------------------------ |  |  | 
|Date: November 13, 2003: |  |  | 
|                         |  |  | 
|                         |  |  |
<PAGE>

                                                                 EXHIBIT 10.22.1

                           TRUSTEE COMPENSATION POLICY

ANNUAL TRUSTEE COMPENSATION SHALL BE AS FOLLOWS:

Non-Employee Trustees

<TABLE>
<CAPTION>
                                                                     2005
                                                                   --------
<S>                                                                <C>
Annual Retainer - Board Members                                    $ 20,000
Annual Retainer - Audit Committee Chairman                         $ 15,000
Annual Retainer - Executive Compensation Committee Chairman        $  7,500
Annual Retainer - Executive Committee Chairman                     $  7,500
Annual Retainer - Governance Committee Chairman                    $  7,500
Annual Retainer - Lead Trustee                                     $  7,500

         Per Board Meeting Attended in Person                      $  1,750*
         Per Board Meeting Attended by Telephone                   $  1,000
Committee Members (other than Chairman)
         Per Committee Meeting Attended in Person                  $  1,250*
         Per Committee Meeting Attended by Telephone               $  1,000
Committee Chairman
         Per Committee Meeting Attended in Person or by Telephone  $  1,750*
</TABLE>

* Plus out of pocket expenses.

Non-employee trustees can elect to receive common shares in lieu of all or a
portion of annual board and committee fees pursuant to the Company's
Non-Employee Trustee Share Plan. Common shares received in lieu of fees under
such plan shall have a fair market value equal to 125% of the amount of fees
foregone.

Non-employee trustees shall also receive an option to purchase 5,000 common
shares upon election to the board, and an additional option to purchase 5,000
common shares following each annual election of trustees that occurs after the
trustee has completed at least one year of service. These options will be issued
under the Company's Second Amended and Restated Employee Share Option and
Restricted Share Plan. The options are to vest in one year after the date of
grant, at an exercise price equal to the fair market value on the day of the
grant.

Non-employee trustees shall further receive a grant of $7,500 of restricted
stock following each annual election of trustees that occurs after the trustee
has completed at least one year of service. This restricted stock will be issued
under the Company's Second Amended and Restated Employee Share Option and
Restricted Share Plan. The restricted stock will be valued based on the fair
market value on the day of the grant and will vest one year after the date of
grant.

Employee trustees are not entitled to any additional compensation for their
service as trustees.

                                       29
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

WILLIAM R. BARRON AND CAROL A.

BARRON, INDIVIDUALLY AND AS

ADMINISTRATORS OF THE ESTATE OF

WILLIAM C. BARRON, DECEASED

 v.

DEPARTMENT OF TRANSPORTATION

OF THE COMMONWEALTH OF

PENNSYLVANIA AND WHITEHALL

TOWNSHIP

 v.

WAYNE A. VASILIOU

PETITION OF: WILLIAM R. BARRON

AND CAROL A. BARRON,

INDIVIDUALLY AND AS

ADMINISTRATORS OF THE ESTATE OF

WILLIAM C. BARRON, DECESED

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

:

No. 561 MAL 2014

Petition for Allowance of Appeal from the

Order of the Commonwealth Court

ORDER

PER CURIAM

AND NOW, this 16th day of December, 2014, the Petition for Allowance of

Appeal is DENIED.
#### ANDREWS v. STATE.

No. 19793.

Court of Criminal Appeals of Texas.

May 25, 1938.

Eddie Roark, of Dallas, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

GRAVES, Judge.

The conviction is for driving an automobile upon the public highway while under the influence of intoxicating liquor; penalty assessed at a fine of $50.00 and confinement in the county jail for five days.

The record before us contains neither a statement of facts nor bills of exception. The indictment seems to be in proper form. All matters of procedure appearing regular, the judgment will be affirmed.
Exhibit 32.2

Certification of Chief Financial Officer

In connection with the Quarterly Report on Form 10-Q of
Knoll, Inc. (the Company) for the period ending June 30, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), Barry L. McCabe, Chief Financial Officer of the Company, certifies,
pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002), that to my knowledge:



| | a. | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
| | -- | -----------------------------------------------------------------------------------------------------------------------------



| | b. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       
|-----------------------
|August 10, 2009        
|                       
|/s/ Barry L. McCabe    
|Barry L. McCabe        
|Chief Financial Officer
#### SNEED v. STATE.

No. 19755.

Court of Criminal Appeals of Texas.

May 11, 1938.

Rehearing Denied June 8, 1938.

Earl M. Greer, of Wills Point, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

CHRISTIAN, Judge.

The offense is possession of whisky in a dry area for the purpose of sale; the punishment, á fine of $125.

The record is before us without a statement of facts.

Appellant brings forward three bills of exception which were filed in the court below on February 28, 1938. In the order overruling the motion for new trial there is no mention of any grant of time for the filing of bills of exception. In the absence of an order of the trial judge directing otherwise, our statute fixes the limit of time for filing bills of exception at thirty days after the ádjournment of the trial term. The trial term of the court ended on January 1, 1938. Manifestly, the bills of exception were filed too late for our consideration. On the 21st of February, 1938, which was more than thirty days after the date of adjournment of the trial term, the trial judge made an order attempting to extend the time for filing the bills of exception. Under the circumstances, the court had no power to make an extending order. Article 760, subd. 5, C.C.P.; Kennedy v. State, 120 Tex.Cr.R. 191, 47 S.W.2d 315.

The judgment is affirmed.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the judges of the Court of Criminal Appeals and approved by the court.

On Motion for Rehearing.

GRAVES, Judge.

Appellant’s bills of exception were not considered by us originally because of *93their being filed too late under the orders appearing in the record. We find the record in the same condition at this time, and we see nothing for us to review. We think our views expressed originally were correct, and this motion is overruled.